A detailed history of Hallmark Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Hallmark Capital Management Inc holds 3,726 shares of ABT stock, worth $381,281. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,726
Previous 3,815 2.33%
Holding current value
$381,281
Previous $419,000 0.95%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$109.52 - $120.96 $9,747 - $10,765
-89 Reduced 2.33%
3,726 $423,000
Q4 2023

Feb 07, 2024

SELL
$90.19 - $110.4 $41,036 - $50,232
-455 Reduced 10.66%
3,815 $419,000
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $36,014 - $43,211
-377 Reduced 8.11%
4,270 $413,000
Q2 2023

Jul 28, 2023

BUY
$100.78 - $112.29 $503 - $561
5 Added 0.11%
4,647 $506,000
Q1 2023

May 03, 2023

BUY
$96.86 - $114.01 $7,748 - $9,120
80 Added 1.75%
4,642 $470,000
Q4 2022

Feb 01, 2023

BUY
$95.06 - $111.52 $2,281 - $2,676
24 Added 0.53%
4,562 $500,000
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $25,834 - $29,912
-267 Reduced 5.56%
4,538 $439,000
Q2 2022

Nov 16, 2022

BUY
$102.07 - $123.37 $27,252 - $32,939
267 Added 5.88%
4,805 $522,000
Q2 2022

Aug 01, 2022

SELL
$102.07 - $123.37 $154,942 - $187,275
-1,518 Reduced 24.01%
4,805 $522,000
Q1 2022

May 02, 2022

SELL
$114.02 - $139.04 $20,067 - $24,471
-176 Reduced 2.71%
6,323 $749,000
Q4 2021

Feb 02, 2022

BUY
$115.53 - $141.46 $27,496 - $33,667
238 Added 3.8%
6,499 $914,000
Q3 2021

Nov 01, 2021

BUY
$116.66 - $129.06 $7,932 - $8,776
68 Added 1.1%
6,261 $739,000
Q2 2021

Aug 03, 2021

BUY
$105.79 - $124.53 $76,380 - $89,910
722 Added 13.2%
6,193 $718,000
Q1 2021

Apr 22, 2021

BUY
$108.84 - $128.23 $108,840 - $128,229
1,000 Added 22.37%
5,471 $655,000
Q4 2020

Feb 02, 2021

SELL
$105.0 - $114.42 $9,660 - $10,526
-92 Reduced 2.02%
4,471 $489,000
Q3 2020

Nov 03, 2020

SELL
$91.64 - $111.29 $618,020 - $750,539
-6,744 Reduced 59.64%
4,563 $497,000
Q2 2020

Jul 28, 2020

SELL
$76.57 - $98.0 $250,996 - $321,244
-3,278 Reduced 22.48%
11,307 $1.03 Million
Q1 2020

Apr 24, 2020

SELL
$62.82 - $91.86 $91,717 - $134,115
-1,460 Reduced 9.1%
14,585 $1.15 Million
Q4 2019

Jan 31, 2020

SELL
$78.51 - $87.4 $173,899 - $193,591
-2,215 Reduced 12.13%
16,045 $1.39 Million
Q3 2019

Nov 01, 2019

BUY
$81.84 - $88.74 $1.02 Million - $1.11 Million
12,503 Added 217.18%
18,260 $1.53 Million
Q2 2019

Aug 08, 2019

SELL
$72.88 - $85.0 $69,017 - $80,495
-947 Reduced 14.13%
5,757 $484,000
Q1 2019

May 09, 2019

BUY
$66.22 - $80.06 $207,732 - $251,148
3,137 Added 87.95%
6,704 $536,000
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $233,852 - $264,921
3,567 New
3,567 $258,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hallmark Capital Management Inc Portfolio

Follow Hallmark Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hallmark Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hallmark Capital Management Inc with notifications on news.